CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Dogwood Therapeutics Enrolls First 200 Patients in Phase 2b Neuropathic Pain Trial

Phase 2Positive
AI Analysis

Summary

Dogwood Therapeutics has enrolled the first 200 patients in a Phase 2b trial for a neuropathic pain treatment. This represents routine clinical trial progress.

Clinical Trial Data

Phase

2b

Patients

200

Importance:5/10
Sentiment:
0.30
Phase 2bneuropathic painpatient enrollmentclinical trial
Related Companies

Read the original article

Published by yahoo_finance on July 20, 2026 1:10 PM

Read Original